golimumab,guselkumab
janssen
['golimumab', 'ibd', 'guselkumab']
at week 38, significantly more patients receiving guselkumab monotherapy as maintenance after receiving combination induction therapy were in clinical remission vs golimumab alone #uegweek #ibd 
The Lancet Gastroenterology & Hepatology publishes high-quality peer-reviewed research and reviews, comment, and news #gastroenterology #hepatology. IF=45.042